Macrostemonoside A promotes visfatin expression in 3T3-L1 cells

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Research

Background:

• Visfatin, a fat cell-secreted factor, exhibits insulin-mimetic properties and plays a role in mitigating insulin resistance and diabetes.
• Natural steroidal saponins, like tigogenin saponins, show anti-diabetic potential, but their mechanisms are unclear.

Purpose of the Study:

• To investigate the effect of macrostemonoside A, a tigogenin steroidal saponin from Allium macrostemon Bung, on visfatin expression in 3T3-L1 adipocytes.

Main Methods:

• Assessed visfatin protein synthesis and secretion in differentiated 3T3-L1 adipocytes treated with macrostemonoside A.
• Quantified visfatin mRNA levels and visfatin promoter-driven luciferase expression.
• Utilized SB-203580 (p38 MAPK inhibitor) and examined PPARgamma expression and DNA-binding activity.

Main Results:

• Macrostemonoside A significantly increased visfatin protein and mRNA levels in a dose- and time-dependent manner.
• The compound elevated visfatin promoter activity, an effect inhibited by p38 MAPK pathway blockade.
• Macrostemonoside A did not alter PPARgamma expression or its DNA-binding capacity for the visfatin promoter.

Conclusions:

• Macrostemonoside A stimulates visfatin expression transcriptionally in adipocytes, partly via the p38 MAPK signaling pathway.
• This regulation of visfatin by macrostemonoside A may contribute to its beneficial effects on insulin resistance and diabetes.